178 related articles for article (PubMed ID: 29414387)
1. Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern.
Alammehrjerdi Z; Ezard N; Dolan K
Asian J Psychiatr; 2018 Jan; 31():49-55. PubMed ID: 29414387
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran.
Shariatirad S; Maarefvand M; Ekhtiari H
Int J Drug Policy; 2013 Nov; 24(6):e115-6. PubMed ID: 23773684
[No Abstract] [Full Text] [Related]
3. Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country.
Alam-mehrjerdi Z; Mokri A; Dolan K
Asian J Psychiatr; 2015 Aug; 16():17-25. PubMed ID: 26123235
[TBL] [Abstract][Full Text] [Related]
4. The Persian methamphetamine use in methadone treatment in Iran: implication for prevention and treatment in an upper-middle income country.
Alam-Mehrjerdi Z; Abdollahi M
Daru; 2015 Nov; 23():51. PubMed ID: 26578071
[TBL] [Abstract][Full Text] [Related]
5. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
Ahmadi J; Razeghian Jahromi L
Trials; 2017 Jun; 18(1):259. PubMed ID: 28587620
[TBL] [Abstract][Full Text] [Related]
6. Oxytocin-enhanced motivational interviewing group therapy for methamphetamine use disorder in men who have sex with men: study protocol for a randomized controlled trial.
Stauffer CS; Moschetto JM; McKernan SM; Hsiang E; Borsari B; Woolley JD
Trials; 2019 Feb; 20(1):145. PubMed ID: 30791944
[TBL] [Abstract][Full Text] [Related]
7. Methadone for the treatment of Prescription Opioids Dependence. A retrospective chart review.
Barrio P; Ezzeldin M; Bruguera P; Pérez A; Mansilla S; Fàbrega M; Lligoña A; Mondón S; Balcells M
Adicciones; 2016 Jun; 29(1):55-60. PubMed ID: 27391853
[TBL] [Abstract][Full Text] [Related]
8. Technology and innovation in the psychosocial treatment of methamphetamine use, risk and dependence.
Kay-Lambkin FJ
Drug Alcohol Rev; 2008 May; 27(3):318-25. PubMed ID: 18368614
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Group Motivational Interviewing in the Degree of Drug Craving in the Addicts Under the Methadone Maintenance Treatment (MMT) in South East of Iran.
Navidian A; Kermansaravi F; Tabas EE; Saeedinezhad F
Arch Psychiatr Nurs; 2016 Apr; 30(2):144-9. PubMed ID: 26992862
[TBL] [Abstract][Full Text] [Related]
10. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapeutic agents in the treatment of methamphetamine dependence.
Morley KC; Cornish JL; Faingold A; Wood K; Haber PS
Expert Opin Investig Drugs; 2017 May; 26(5):563-578. PubMed ID: 28351169
[TBL] [Abstract][Full Text] [Related]
12. A Randomized Controlled Trial of Brief Cognitive Behavioral Therapy for Regular Methamphetamine Use in Methadone Treatment.
Alammehrjerdi Z; Briggs NE; Biglarian A; Mokri A; Dolan K
J Psychoactive Drugs; 2019; 51(3):280-289. PubMed ID: 30835643
[TBL] [Abstract][Full Text] [Related]
13. Beyond methamphetamine: Documenting the implementation of the Matrix model of substance use treatment for opioid users in a South African setting.
Magidson JF; Gouse H; Burnhams W; Wu CY; Myers B; Joska JA; Carrico AW
Addict Behav; 2017 Mar; 66():132-137. PubMed ID: 27940387
[TBL] [Abstract][Full Text] [Related]
14. Forensic Toxicology Perspectives of Methadone-associated Deaths in Tehran, Iran, a 7-year Overview.
Akhgari M; Amini-Shirazi N; Iravani FS
Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):436-441. PubMed ID: 29076627
[TBL] [Abstract][Full Text] [Related]
15. Using ADAPT-ITT framework to tailor evidence-based interventions for addressing methamphetamine use among methadone patients in Vietnam.
Giang LM; Trang NT; Thuy DT; Nguyen HH; Diep NB; Van HTH; Truc TT; Reback CJ; Li M; Van Dung D; Shoptaw S
Drug Alcohol Rev; 2023 Nov; 42(7):1667-1679. PubMed ID: 37614129
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of intensive motivational interviewing for methamphetamine dependence.
Polcin DL; Bond J; Korcha R; Nayak MB; Galloway GP; Evans K
J Addict Dis; 2014; 33(3):253-65. PubMed ID: 25115166
[TBL] [Abstract][Full Text] [Related]
17. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
[TBL] [Abstract][Full Text] [Related]
18. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
[TBL] [Abstract][Full Text] [Related]
19. Major physical and psychological harms of methamphetamine use.
Darke S; Kaye S; McKetin R; Duflou J
Drug Alcohol Rev; 2008 May; 27(3):253-62. PubMed ID: 18368606
[TBL] [Abstract][Full Text] [Related]
20. Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial.
Rezaei F; Ghaderi E; Mardani R; Hamidi S; Hassanzadeh K
Fundam Clin Pharmacol; 2016 Jun; 30(3):282-9. PubMed ID: 26751259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
